Eutropin Plus inj.
重组人生长激素（rhGH）1瓶，附溶剂的MCT预充式注射器
白色或几乎白色粉末，含有无色瓶
在儿童生长障碍由于垂体生长激素的疾病
在儿童生长障碍由于垂体生长激素障碍：
每公斤体重为人类生长激素的缓释0.5毫克皮下注射，每周一次。
recombinant human Growth Hormone (rhGH)
9mg : 668901500
24mg : 668901410
Product Name
Eutropin
Composition
Each vial contains 4 or15 IU of recombinant human growth hormone (somatropin).
Indication
Short stature due to GHD
Short stature due to Turner syndrome
Short stature caused by chronic renal insufficiency
Replacement therapy in adults with GH deficiency of either childhood- or adult-onset etiology (confirmed by an appropriate GH stimulation test)
Short stature due to Turner syndrome
Short stature caused by chronic renal insufficiency
Replacement therapy in adults with GH deficiency of either childhood- or adult-onset etiology (confirmed by an appropriate GH stimulation test)
Dosage and Administration
1. Short stature due to an inadequate secretion of endogenous growth hormone (Growth Hormone Deficeincy, GHD): 0.5~0.6 IU/kg/week or 12 IU/㎡ body surface area/weak in 3 ~ 6 divided doses weekly by SC
2. Short stature caused by Turner syndrome: 1 IU/kg in 6 ~ 7 divided doses weekly by SC or IM
3. Short stature caused by chronic renal insufficiency: 0.15 IU per kg of body weight per day is given by subcutaneous injection.
4. Short stature in children born Small for Gestational Age (SGA): 0.48 mg/kg/week is given devided into 6 ~ 7 subcutaneous injections.
5. Replacement therapy in adults with GH deficiency of either childhood- or adult-onset etiology (confirmed by an appropriate GH stimulation test): The recommended dosage at the start of therapy is 0.125IU (0.04mg)/kg/wk, divided into 6 ~ 7 injections. The dose may be increased according to individual patient requirements to a maximum of 0.25 IU (0.08mg)/kg/wk.
2. Short stature caused by Turner syndrome: 1 IU/kg in 6 ~ 7 divided doses weekly by SC or IM
3. Short stature caused by chronic renal insufficiency: 0.15 IU per kg of body weight per day is given by subcutaneous injection.
4. Short stature in children born Small for Gestational Age (SGA): 0.48 mg/kg/week is given devided into 6 ~ 7 subcutaneous injections.
5. Replacement therapy in adults with GH deficiency of either childhood- or adult-onset etiology (confirmed by an appropriate GH stimulation test): The recommended dosage at the start of therapy is 0.125IU (0.04mg)/kg/wk, divided into 6 ~ 7 injections. The dose may be increased according to individual patient requirements to a maximum of 0.25 IU (0.08mg)/kg/wk.
How Supplied
4 IU/vial × 1, 5 vials/pack (with solvent)
15 IU/vial × 1 vial/pack (with solvent)
15 IU/vial × 1 vial/pack (with solvent)
Storage Condition
Store in hermetic container at 2~8℃